Empirical therapy in febrile granulocytopenic patients.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000150:complications*; D000583:Amikacin / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy*; D001803:Blood Transfusion; D002228:Carbenicillin / Q000008:administration & dosage; D002512:Cephalothin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005260:Female; D005334:Fever / Q000150:complications*; D005839:Gentamicins / Q000008:administration & dosage; D006098:Granulocytes / Q000637:transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D014184:Transplantation, Homologous
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D000583:Amikacin; D002228:Carbenicillin; D002512:Cephalothin